Davide Bolignano
Davide Bolignano
Verified email at unicz.it - Homepage
Title
Cited by
Cited by
Year
Neutrophil Gelatinase–Associated lipocalin (NGAL) as a marker of kidney damage
D Bolignano, V Donato, G Coppolino, S Campo, A Buemi, A Lacquaniti, ...
American Journal of Kidney Diseases 52 (3), 595-605, 2008
5672008
Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease
D Bolignano, A Lacquaniti, G Coppolino, V Donato, S Campo, MR Fazio, ...
Clinical Journal of the American Society of Nephrology 4 (2), 337-344, 2009
5182009
Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients
D Bolignano, A Lacquaniti, G Coppolino, V Donato, MR Fazio, G Nicocia, ...
Kidney and Blood Pressure Research 32 (2), 91-98, 2009
2242009
Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene
D Bolignano, V Donato, A Lacquaniti, MR Fazio, C Bono, G Coppolino, ...
Cancer letters 288 (1), 10-16, 2010
1942010
Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease
D Bolignano, G Coppolino, S Campo, C Aloisi, G Nicocia, N Frisina, ...
American journal of nephrology 27 (4), 373-378, 2007
1852007
Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients
D Bolignano, G Coppolino, S Campo, C Aloisi, G Nicocia, N Frisina, ...
Nephrology Dialysis Transplantation 23 (1), 414-416, 2008
1792008
The aging kidney revisited: a systematic review
D Bolignano, F Mattace-Raso, EJG Sijbrands, C Zoccali
Ageing research reviews 14, 65-80, 2014
1772014
Exercise in patients on dialysis: a multicenter, randomized clinical trial
F Manfredini, F Mallamaci, G D’Arrigo, R Baggetta, D Bolignano, C Torino, ...
Journal of the American Society of Nephrology 28 (4), 1259-1268, 2017
1542017
Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease
D Bolignano, A Lacquaniti, G Coppolino, S Campo, A Arena, M Buemi
Kidney and Blood Pressure Research 31 (4), 255-258, 2008
1542008
Effects of weight loss on renal function in obese CKD patients: a systematic review
D Bolignano, C Zoccali
Nephrology Dialysis Transplantation 28 (suppl_4), iv82-iv98, 2013
1432013
Aldosterone antagonists for preventing the progression of chronic kidney disease
D Bolignano, SC Palmer, SD Navaneethan, GFM Strippoli
Cochrane Database of Systematic Reviews, 2014
1402014
Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure
D Bolignano, G Basile, P Parisi, G Coppolino, G Nicocia, M Buemi
Rejuvenation research 12 (1), 7-14, 2009
1302009
Gitelman syndrome: consensus and guidance from a kidney disease: improving global outcomes (KDIGO) controversies conference
A Blanchard, D Bockenhauer, D Bolignano, LA Calo, E Cosyns, ...
Kidney international 91 (1), 24-33, 2017
1272017
Pulmonary hypertension in CKD
D Bolignano, S Rastelli, R Agarwal, D Fliser, Z Massy, A Ortiz, A Wiecek, ...
American journal of kidney diseases 61 (4), 612-622, 2013
1252013
From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology
D Bolignano, G Coppolino, A Lacquaniti, M Buemi
European journal of clinical investigation 40 (3), 273-276, 2010
1082010
Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macroproteinuric patients with worsening renal function
D Bolignano, G Coppolino, A Lacquaniti, G Nicocia, M Buemi
Kidney & blood pressure research 31 (4), 274, 2008
1062008
Clinical practice guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR< 45 mL/min)
Guideline Development Group, H Bilo, L Coentrão, C Couchoud, A Covic, ...
Nephrology Dialysis Transplantation 30 (suppl_2), ii1-ii142, 2015
1052015
Paricalcitol and endothelial function in chronic kidney disease trial
C Zoccali, G Curatola, V Panuccio, R Tripepi, P Pizzini, M Versace, ...
Hypertension 64 (5), 1005-1011, 2014
1002014
Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology
D Bolignano, A Cabassi, E Fiaccadori, E Ghigo, R Pasquali, A Peracino, ...
Clinical Chemistry and Laboratory Medicine (CCLM) 52 (10), 1447-1456, 2014
952014
Renal biopsy in 2015-from epidemiology to evidence-based indications
M Fiorentino, D Bolignano, V Tesar, A Pisano, W Van Biesen, G Tripepi, ...
American Journal of Nephrology 43 (1), 1-19, 2016
912016
The system can't perform the operation now. Try again later.
Articles 1–20